Merck & Company Inc (MRK)vsUtah Medical Products Inc (UTMD)
MRK
Merck & Company Inc
$109.18
-1.60%
HEALTHCARE · Cap: $274.03B
UTMD
Utah Medical Products Inc
$65.42
+0.60%
HEALTHCARE · Cap: $207.06M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 173115% more annual revenue ($65.01B vs $37.53M). UTMD leads profitability with a 28.9% profit margin vs 28.1%. MRK appears more attractively valued with a PEG of 3.36. MRK earns a higher WallStSmart Score of 59/100 (C).
MRK
Buy59
out of 100
Grade: C
UTMD
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-13.2%
Fair Value
$96.48
Current Price
$109.18
$12.70 premium
Margin of Safety
-22.8%
Fair Value
$51.90
Current Price
$65.42
$13.52 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 32.8%
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Generating 1.8B in free cash flow
Keeps 29 of every $100 in revenue as profit
Reasonable price relative to book value
Strong operational efficiency at 29.4%
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Earnings declined 19.3%
Smaller company, higher risk/reward
Expensive relative to growth rate
Revenue declined 10.2%
Earnings declined 11.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.1% and operating margin at 32.8%.
Bull Case : UTMD
The strongest argument for UTMD centers on Profit Margin, Price/Book, Operating Margin. Profitability is solid with margins at 28.9% and operating margin at 29.4%.
Bear Case : MRK
The primary concerns for MRK are Piotroski F-Score, PEG Ratio, EPS Growth.
Bear Case : UTMD
The primary concerns for UTMD are Market Cap, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
MRK profiles as a value stock while UTMD is a declining play — different risk/reward profiles.
UTMD carries more volatility with a beta of 0.35 — expect wider price swings.
MRK is growing revenue faster at 5.0% — sustainability is the question.
MRK generates stronger free cash flow (1.8B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (59/100 vs 46/100), backed by strong 28.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Utah Medical Products Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?